 | ||||||
| "anti diabetes" | ||||||
| NEWS | ||||||
| Citi Sees Light at End of Hanmi's Pipeline ... R&D assets, (b) out-licensing of anti-diabetes pipeline offering significant value upside potential, (c) an incremental bottoming out of fundamentals.
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.